Strand (Biotechnology) Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Employees
-
373
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$53.1M
Strand (Biotechnology) General Information
Description
Provider of sequence-based diagnostics and clinical genomic data interpretation services intended to identify the right therapy for cancer through genomic testing. The company's services offer informatics products and services for research biologists, chemists, and toxicologists that combine advanced visualization, predictive systems modeling, data integration, and scientific content management, enabling doctors to identify individuals and families with a high risk of hereditary cancer and provide them with personalized surveillance and risk-reduction measures.
Contact Information
Website
strandls.com(Operating Subsidiary)
Corporate Office
- UAS Alumni Association Building
- Veterinary College Campus, Bellary Road
- Bangalore, Karnataka 560024
- India
Corporate Office
- UAS Alumni Association Building
- Veterinary College Campus, Bellary Road
- Bangalore, Karnataka 560024
- India
Strand (Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Merger/Acquisition | 03-Sep-2021 | $53.1M | Completed | Generating Revenue | ||
| 10. Later Stage VC | 08-Feb-2018 | Completed | Generating Revenue | |||
| 9. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 8. Reverse Merger | 14-Mar-2016 | Cancelled | Generating Revenue | |||
| 7. Later Stage VC | 01-Jan-2016 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 06-May-2015 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 01-Dec-2014 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B) | 11-Feb-2013 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | $5M | Completed | Startup | |||
| 2. Grant | 01-Jul-2004 | $1M | $5M | Completed | Startup |
Strand (Biotechnology) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Preference | ||||||||
| Ordinary | 1,222,169 | $0.156604 | $3.96 | $3.96 | 1x | $3.96 | 4.94% |
Strand (Biotechnology) Comparisons
Industry
Financing
Details
Strand (Biotechnology) Competitors (8)
One of Strand (Biotechnology)’s 8 competitors is Foundation Medicine, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Foundation Medicine | Formerly VC-backed | Cambridge, MA | ||||
| One BioMed | Venture Capital-Backed | Singapore, Singapore | ||||
| Genotypic Technology | Corporation | Bengaluru, India | ||||
| Datar Cancer Genetics | Venture Capital-Backed | Nashik, India | ||||
| Biodesix | Formerly VC-backed | Louisville, CO |
Strand (Biotechnology) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Strand (Biotechnology) Patents
Strand (Biotechnology) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10734117-B2 | Apparatuses and methods for determining a patient's response to multiple cancer drugs | Active | 02-Mar-2015 | ||
| US-20190006048-A1 | Apparatuses and methods for determining a patient's response to multiple cancer drugs | Active | 02-Mar-2015 | ||
| US-20130323767-A1 | Method to identify liver toxicity using metabolite profiles | Inactive | 04-Mar-2011 | ||
| CA-2824144-A1 | Method to identify liver toxicity using metabolite profiles | Inactive | 04-Mar-2011 | ||
| EP-2656071-A1 | Method to identify liver toxicity using metabolite profiles | Active | 04-Mar-2011 | G01N33/5067 |
Strand (Biotechnology) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Strand (Biotechnology) Former Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Ascent Capital | Growth/Expansion | Minority | ||
| Biomark Capital | PE/Buyout | Minority | ||
| Burrill & Co | Merchant Banking Firm | Minority | ||
| Centre for Cellular And Molecular Platforms | Accelerator/Incubator |
Strand (Biotechnology) Acquisitions (2)
Strand (Biotechnology)’s most recent deal was a Merger/Acquisition with Quest Diagnostics India. The deal was made on 24-Dec-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Quest Diagnostics India | 24-Dec-2018 | Merger/Acquisition | Drug Discovery | ||
| Triesta Sciences | 02-Jan-2018 | Merger/Acquisition | Laboratory Services (Healthcare) |
Strand (Biotechnology) FAQs
-
When was Strand (Biotechnology) founded?
Strand (Biotechnology) was founded in 2000.
-
Where is Strand (Biotechnology) headquartered?
Strand (Biotechnology) is headquartered in Bangalore, India.
-
What is the size of Strand (Biotechnology)?
Strand (Biotechnology) has 373 total employees.
-
What industry is Strand (Biotechnology) in?
Strand (Biotechnology)’s primary industry is Biotechnology.
-
Is Strand (Biotechnology) a private or public company?
Strand (Biotechnology) is a Private company.
-
What is the current valuation of Strand (Biotechnology)?
The current valuation of Strand (Biotechnology) is .
-
What is Strand (Biotechnology)’s current revenue?
The current revenue for Strand (Biotechnology) is .
-
How much funding has Strand (Biotechnology) raised over time?
Strand (Biotechnology) has raised $38.1M.
-
Who are Strand (Biotechnology)’s investors?
, Ascent Capital, Biomark Capital, Burrill & Co, and Centre for Cellular And Molecular Platforms are 5 of 15 investors who have invested in Strand (Biotechnology).
-
Who are Strand (Biotechnology)’s competitors?
Foundation Medicine, One BioMed, Genotypic Technology, Datar Cancer Genetics, and Biodesix are some of the 8 competitors of Strand (Biotechnology).
-
When was Strand (Biotechnology) acquired?
Strand (Biotechnology) was acquired on 03-Sep-2021.
-
Who acquired Strand (Biotechnology)?
Strand (Biotechnology) was acquired by Reliance Industries.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
